Lebwohl M, Stein Gold L, Gooderham M, Papp K, Ferris L, Adam D, Hong HC- ho, Kircik L, Zirwas M, Burnett P, Higham R, Krupa D, Berk D. Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults With Chronic Plaque Psoriasis From a 52-Week, Phase 2 Open-Label Safety Trial. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 3];7(2):s111. Available from: https://jofskin.org/33014/index.php/skin/article/view/2040